Erratum: Disulfiram combined with chemoimmunotherapy potentiates pancreatic cancer treatment efficacy through the activation of cGAS-STING signaling pathway via suppressing PARP1 expression.
- DOI
- 10.62347/fsin8036
- Published
- 2026
- Container
- American journal of cancer research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.62347/fsin8036,
title = {Erratum: Disulfiram combined with chemoimmunotherapy potentiates pancreatic cancer treatment efficacy through the activation of cGAS-STING signaling pathway via suppressing PARP1 expression.},
author = {Huang S and Xie P and Huang X and Chen Z and Yang J and Wang J and Liu C and Li H and Zhou B},
year = {2026},
journal = {American journal of cancer research},
doi = {10.62347/fsin8036},
url = {https://doi.org/10.62347/fsin8036}
}RIS
TY - JOUR TI - Erratum: Disulfiram combined with chemoimmunotherapy potentiates pancreatic cancer treatment efficacy through the activation of cGAS-STING signaling pathway via suppressing PARP1 expression. AU - Huang S AU - Xie P AU - Huang X AU - Chen Z AU - Yang J AU - Wang J AU - Liu C AU - Li H AU - Zhou B PY - 2026 JO - American journal of cancer research DO - 10.62347/fsin8036 UR - https://doi.org/10.62347/fsin8036 ER -
APA
S, H., P, X., X, H., Z, C., J, Y., J, W., C, L., H, L., & B, Z. (2026). Erratum: Disulfiram combined with chemoimmunotherapy potentiates pancreatic cancer treatment efficacy through the activation of cGAS-STING signaling pathway via suppressing PARP1 expression.. American journal of cancer research. https://doi.org/10.62347/fsin8036
Source records
- pubmed · retrieved 2026-09-25T10:59:57.202Z